Shanghai Fosun Pharmaceutical (Group) Co., Ltd. - Net Worth and Insider Trading

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Net Worth

The estimated net worth of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is at least $1.2 Billion dollars as of 2024-11-12. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is the of Sisram Medical Ltd and owns about 334,504,800 shares of Sisram Medical Ltd (HKSE:01696) stock worth over $1.2 Billion. Details can be seen in Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has not made any transactions after 2023-12-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

To

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. owns 1 companies in total, including Sisram Medical Ltd (HKSE:01696) .

Click here to see the complete history of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s form 4 insider trades.

Insider Ownership Summary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Ticker Comapny Transaction Date Type of Owner
HKSE:01696 Sisram Medical Ltd 2023-12-08

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Latest Holdings Summary

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. currently owns a total of 1 stock. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. owns 334,504,800 shares of Sisram Medical Ltd (HKSE:01696) as of December 8, 2023, with a value of $1.2 Billion.

Latest Holdings of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:01696 Sisram Medical Ltd 2023-12-08 334,504,800 3.63 1,214,252,424

Holding Weightings of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.


Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has made a total of 3 transactions in Sisram Medical Ltd (HKSE:01696) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sisram Medical Ltd is the sale of 0 shares on December 8, 2023, which brought Shanghai Fosun Pharmaceutical (Group) Co., Ltd. around $0.

Insider Trading History of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Trading Performance

GuruFocus tracks the stock performance after each of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is 12.97%. GuruFocus also compares Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Shanghai Fosun Pharmaceutical (Group) Co., Ltd. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.08 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.24 LIMIT LIMIT LIMIT LIMIT LIMIT

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Ownership Network

Ownership Network List of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

No Data

Ownership Network Relation of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Insider Network Chart

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Owned Company Details

What does Sisram Medical Ltd do?

Who are the key executives at Sisram Medical Ltd?

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is the of Sisram Medical Ltd. Other key executives at Sisram Medical Ltd include Fosun Holdings Limited , Fosun International Holdings Ltd. , and Fosun International Limited .

Sisram Medical Ltd (HKSE:01696) Insider Trades Summary

Over the past 18 months, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. made 1 insider transaction in Sisram Medical Ltd (HKSE:01696) with a net sale of 0. Other recent insider transactions involving Sisram Medical Ltd (HKSE:01696) include a net sale of 0 shares made by Fosun International Limited , a net sale of 0 shares made by Shanghai Fosun High Technology (Group) Co., Ltd. , and a net sale of 0 shares made by Chindex Medical Limited .

In summary, during the past 3 months, insiders sold 0 shares of Sisram Medical Ltd (HKSE:01696) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sisram Medical Ltd (HKSE:01696) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sisram Medical Ltd (HKSE:01696)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sisram Medical Ltd Insider Transactions

No Available Data

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.. Currently GuruFocus does not have mailing address information for Shanghai Fosun Pharmaceutical (Group) Co., Ltd..